ArticleInfection and drug resistance2026
Evolution in Epidemiology and Antimicrobial Resistance Patterns of Bacteria Among Dermatology Patients: A Retrospective Study in a Tertiary Dermatology Hospital in China (2018-2023).
Article in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study analyzed the epidemiology and antimicrobial resistance of dermatology patients to supplement general surveillance with dermatology-related data, guide the prudent use of antimicrobials, provide a template for antimicrobial stewardship programme and interrupt the spread of drug-resistant bacteria. Methods: A retrospective study analyzed bacterial isolates from dermatology patients between 2018 and 2023. Statistical analysis was carried out using WHONET 2023, IBM SPSS 26, Excel 2021, and R 4.3.3, using chi-square and Cochran-Armitage tests to identify differences and trends. Results: The study found the bacterial isolation rate of 32.88% in dermatology patients. Positive cultures were more common in males, aged 60 or older, outpatients, and dermatologic surgery patients. Gram-positive bacteria (GPB) isolation rates increased from 2018 to 2020 and decreased thereafter. Secretion was most common in positive specimen types. Primary infections had higher isolation rates than secondary infections. Eczema, dermatitis, and herpes zoster were the most diagnosed skin conditions. Conclusion: The findings revealed that the bacterial distribution and antimicrobial resistance patterns among dermatology patients exhibit distinct characteristics. Ongoing surveillance is crucial for tracking these patterns and supporting informed decisions on anti-infective therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.